The BID Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-121241 |
| Réf. fabricant | 18256013 |
| À utiliser avec (application) | Western Blot |
| Lignée cellulaire | The lysate was created in HEK293T cells, using plasmid ID RC27261 and based on accession number NM_1196. The protein contains a C-terminal DDK tag. |
| Quantité | 0.1 mg |
| Tampon de stockage | RIPA buffer |
| Pureté | Protein |
| Spécificité du test | Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 2, mRNA. |
| Contenu et stockage | Store at -80 C. Avoid freeze-thaw cycles. |
| Catégorie de recherche | Apoptosis, Cancer, Tumor Suppressors |
| Cible | BID |
| Synonyme | apoptic death agonist, BH3 interacting domain death agonist, BH3-interacting domain death agonist, BID isoform ES(1 b), BID isoform L(2), BID isoform Si6, desmocollin type 4, FP497, Human BID coding sequence, MGC15319, MGC42355, p22 BID, tbid |
| Symbole de gène(s) | BID |
| Protein State | Native |
